v-Src SH3-enhanced interaction with focal adhesion kinase at beta 1 integrin-containing invadopodia promotes cell invasion. - Wikidata - awgldk - TriplyDB

v-Src SH3-enhanced interaction with focal adhesion kinase at beta 1 integrin-containing invadopodia promotes cell invasion.

v-Src SH3-enhanced interaction with focal adhesion kinase at beta 1 integrin-containing invadopodia promotes cell invasion.

http://www.wikidata.org/entity/Q30167613

about

The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function Differential regulation of cell motility and invasion by FAK The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells The interplay between the proteolytic, invasive, and adhesive domains of invadopodia and their roles in cancer invasion Protein receptor-independent plasma membrane remodeling by HAMLET: a tumoricidal protein-lipid complex.Altering FAK-paxillin interactions reduces adhesion, migration and invasion processes Spatiotemporal regulation of Src and its substrates at invadosomes Laminin-332-beta1 integrin interactions negatively regulate invadopodia Phosphoinositide 3-kinase p85beta regulates invadopodium formation.SH3 domain of c-Src governs its dynamics at focal adhesions and the cell membrane.FAK competes for Src to promote migration against invasion in melanoma cells.Met receptor tyrosine kinase signals through a cortactin-Gab1 scaffold complex, to mediate invadopodia Active Rho is localized to podosomes induced by oncogenic Src and is required for their assembly and function.Quantitative in vivo imaging of the effects of inhibiting integrin signaling via Src and FAK on cancer cell movement: effects on E-cadherin dynamics.Discoidin domain receptor 1 controls linear invadosome formation via a Cdc42-Tuba pathway.FRNK blocks v-Src-stimulated invasion and experimental metastases without effects on cell motility or growth.Dermal wound healing is subject to redox control Podosomes and Invadopodia: Related structures with Common Protein Components that May Promote Breast Cancer Cellular Invasion.Understanding the roles of FAK in cancer: inhibitors, genetic models, and new insights Focal adhesion kinase as a potential target in oncology.Tumor suppressive protein gene associated with retinoid-interferon-induced mortality (GRIM)-19 inhibits src-induced oncogenic transformation at multiple levels.Role of the Na/H exchanger NHE1 in cell migration.LPA-mediated migration of ovarian cancer cells involves translocalization of Gαi2 to invadopodia and association with Src and β-pix Regulation of invadopodia by mechanical signaling.Extracellular matrix rigidity promotes invadopodia activity.ADP-ribosylation factor 1 expression regulates epithelial-mesenchymal transition and predicts poor clinical outcome in triple-negative breast cancer.FAK alters invadopodia and focal adhesion composition and dynamics to regulate breast cancer invasion Podosome-like structures of non-invasive carcinoma cells are replaced in epithelial-mesenchymal transition by actin comet-embedded invadopodia.Receptor protein-tyrosine phosphatase α regulates focal adhesion kinase phosphorylation and ErbB2 oncoprotein-mediated mammary epithelial cell motility.Abl interactor 1 regulates Src-Id1-matrix metalloproteinase 9 axis and is required for invadopodia formation, extracellular matrix degradation and tumor growth of human breast cancer cells.Soft matrix is a natural stimulator for cellular invasiveness.Insulin-like growth factor binding protein-2 regulates β-catenin signaling pathway in glioma cells and contributes to poor patient prognosis.Benzo-[a]-pyrene induces FAK activation and cell migration in MDA-MB-231 breast cancer cells.Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model.Migration of human melanoma cells depends on extracellular pH and Na+/H+ exchange.Focal adhesion kinases in adhesion structures and disease.IGF-1 receptor transactivation mediates Src-dependent cortactin phosphorylation in response to angiotensin II.Expression of GRP and its receptor in well-differentiated colon cancer cells correlates with the presence of focal adhesion kinase phosphorylated at tyrosines 397 and 407.Activation of adenovirus type 2 early region 4 ORF4 cytoplasmic death function by direct binding to Src kinase domain.Focal adhesion kinase overexpression: correlation with lymph node metastasis and shorter survival in oral squamous cell carcinoma.

P2860

Q24614572-C314482A-0DBD-45D7-9336-14507019E802 Q24673170-F514179E-9AF0-4FE2-AEDA-6197C768754E Q24795765-C680CE24-BCAB-44B2-9EDA-F0B0ACBC16C2 Q27003744-1E336116-E2EC-41CA-AE53-805CF5478211 Q27306774-E3189190-74DE-45BC-9381-F87CBFEF6B36 Q27314883-9B73188D-2299-4E0A-840D-1AC83720C4FB Q28391160-34298D93-3370-4B2E-874A-B3584907CC6F Q28571911-1ADCE68F-1472-4D9F-8EE3-6B8F20A9532F Q29347240-AE8E7B36-2094-44DE-B581-9C936A2A3980 Q30009127-3F6E4CB8-9A4B-4C95-8D63-E519A1486CC8 Q30009333-1CF0DCD4-892E-4142-8B85-C734451A725B Q30010161-CF2B9593-5C7E-4731-818E-1C508F6C3B76 Q30443444-3D599A74-6A99-4C1F-8FAC-87975171D71F Q30499765-3541053D-68EF-4A5E-89E6-DAC7A1829BFA Q30601549-F0064BA5-AA53-4F35-8832-202CB0D4E7D0 Q34360984-9CC62FAF-415B-4B7B-AD3E-777632D94DC9 Q34425336-3EDB34AC-81B1-4AF8-9C37-14ECE819683B Q34897371-6720E691-0A62-4731-955A-B9444E763FF1 Q35009792-CBCEF5EB-669B-436F-84C9-307FB27C712D Q35058125-05F54C54-2378-4C48-B58B-04AED9A4DCE3 Q36007492-37A817F9-56EA-45B4-9CE0-F79B9FF318A1 Q36492490-6D4D406D-E256-4111-B7ED-DEFDABEB5713 Q36767090-6F18BC44-6C22-46CB-A9C5-14997EFBDB2B Q36853200-75269019-F2B1-48BF-9311-13A6D8628496 Q36914347-E169F5BC-449C-40E4-A77A-8260F9DF3EC6 Q37085887-278A596C-7A58-423F-B25B-2D2B849736A9 Q37237616-313A1D42-279A-4916-8AB1-4ACCE9C377E9 Q37310999-C92E1975-5847-40D6-BA83-F16C51715DFA Q37415599-FE63D724-19CB-44CB-BC45-33BB36700D29 Q37472144-227F46B3-128C-46CF-AE5F-487876BECFEE Q37582531-2CDD5D34-6E29-4270-9B24-EE58257FEF0D Q38780791-0B95C780-24D4-431B-BAC7-73C664EF633E Q39108742-0FF43696-A129-43EB-8AAE-5EBEC36CF464 Q40302237-EB0C4780-5621-4C64-B77C-54480B27AEC2 Q40411551-E4136FE5-2BE7-4F9A-9C88-070B9DD3034F Q42257455-CF9EDB9D-7438-45C7-93EA-CC1E2CDE6AB0 Q43246055-37F2F14D-1CE2-4FC0-87D8-83AB8C2EF4DC Q44519414-194495B1-36BB-486D-8E0B-5D4E9E2208BB Q44834961-07746C94-66C4-4CDD-B4A5-D9FF217F27C0 Q45351701-B4F87D82-4C50-40B9-9D74-F8AAE54CDE4D

P2860

v-Src SH3-enhanced interaction with focal adhesion kinase at beta 1 integrin-containing invadopodia promotes cell invasion.

http://www.wikidata.org/entity/Q30167613

description

2002 nî lūn-bûn

@nan

2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

v-Src SH3-enhanced interaction ...... opodia promotes cell invasion.

@ast

v-Src SH3-enhanced interaction ...... opodia promotes cell invasion.

@en

type

label

v-Src SH3-enhanced interaction ...... opodia promotes cell invasion.

@ast

v-Src SH3-enhanced interaction ...... opodia promotes cell invasion.

@en

prefLabel

v-Src SH3-enhanced interaction ...... opodia promotes cell invasion.

@ast

v-Src SH3-enhanced interaction ...... opodia promotes cell invasion.

@en

P1433

Q30167613-039F9564-7485-4A5F-A1E1-A6DBF8BCF185

P1476

Q30167613-1810A873-5507-4FDF-8478-CFBF4EF68E01

P2093

Q30167613-13D6CC02-97C0-4635-9735-42DCDF63E620

Q30167613-232B0E4D-AF19-45DE-BEC1-2DFFA3E2228F

Q30167613-258889E8-D1F9-4467-A86D-492D84BEEA41

P2860

Q30167613-0DE301A4-A9BE-46DD-827E-D18D8E881E38

Q30167613-3095B46B-DA0A-4828-B3F9-33CBCDDB7322

Q30167613-32FD1B19-83B9-47CB-8698-C39E319283B0

Q30167613-425F49CA-90A0-48CF-8A7B-101CA04A26DF

Q30167613-537CF6CB-BF81-4644-97DA-F50857F40F69

Q30167613-5F689217-13FD-450D-BF63-3B381B319488

Q30167613-69016469-36D2-4D08-83D0-E91FB9ABCFED

Q30167613-81AF02C8-270B-4100-A367-5B6E2FBA6DFE

Q30167613-855CB6E0-1F93-4B70-A238-39B2B9F1B5DE

Q30167613-8693D40F-0071-4B2D-B848-A11D895BBDB7

P304

Q30167613-5EFD8FA8-8204-4A1B-BFE1-ED8019FEF28E

P31

Q30167613-E8D3C3A7-292B-4F11-9283-08B124E3B571

P356

Q30167613-7096091C-7ECE-4759-932B-E5B6C8FA4317

P407

Q30167613-0698CED6-81C9-4AE9-96D4-6EC3C8110EE4

P433

Q30167613-60525DA0-17E9-4702-8046-76E9897CF241

P478

Q30167613-17EA927F-3C2A-4391-A5DA-F83B12AD232D

P50

Q30167613-781FBB79-727D-4F16-82FC-F4E42EEB1CA3

P577

Q30167613-0DF508D4-9DDA-4EBB-BB25-8F077B51870C

P698

Q30167613-F9BE25BE-1772-47E7-B159-545EAA2E4DBC

P921

Q30167613-301CEDE7-3F8A-4416-A2A6-4D63D0AB21E0

P356

P1433

Journal of Biological Chemistry

P1476

v-Src SH3-enhanced interaction ...... opodia promotes cell invasion.

@en

P2093

Christof R Hauck

http://www.w3.org/2001/XMLSchema#string

Datsun A Hsia

http://www.w3.org/2001/XMLSchema#string

David D Schlaepfer

http://www.w3.org/2001/XMLSchema#string

P2860

pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions.

Fibronectin-stimulated signaling from a focal adhesion kinase-c-Src complex: involvement of the Grb2, p130cas, and Nck adaptor proteins

Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions

Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation

Signaling through focal adhesion kinase

Biochemical signals and biological responses elicited by the focal adhesion kinase

Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130Cas

Plasma membrane-associated pY397FAK is a marker of cytotrophoblast invasion in vivo and in vitro

Pyk2 and Src-family protein-tyrosine kinases compensate for the loss of FAK in fibronectin-stimulated signaling events but Pyk2 does not fully function to enhance FAK- cell migration.

Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase

P304

12487-12490

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.C100760200

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

277

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-02-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11839732

http://www.w3.org/2001/XMLSchema#string

P921